Figure 4.
Cumulative incidence of progression to advanced MDS for patients with RA and either normal karyotype, monosomy 7, trisomy 8, or other abnormalities at the time of diagnosis. Patients who underwent SCT were censored at the time of transplantation.

Cumulative incidence of progression to advanced MDS for patients with RA and either normal karyotype, monosomy 7, trisomy 8, or other abnormalities at the time of diagnosis. Patients who underwent SCT were censored at the time of transplantation.

Close Modal

or Create an Account

Close Modal
Close Modal